Pandha, H., Harrington, K., Ralph, C., Melcher, A., Grose, M., & Shafren, D. (2015). Phase I/II storm study: Intravenous delivery of a novel oncolytic immunotherapy agent, Coxsackievirus A21, in advanced cancer patients. J Immunother Cancer.
Citação norma ChicagoPandha, Hardev, Kevin Harrington, Christy Ralph, Alan Melcher, Mark Grose, and Darren Shafren. "Phase I/II Storm Study: Intravenous Delivery of a Novel Oncolytic Immunotherapy Agent, Coxsackievirus A21, in Advanced Cancer Patients." J Immunother Cancer 2015.
Deismireacht MLAPandha, Hardev, et al. "Phase I/II Storm Study: Intravenous Delivery of a Novel Oncolytic Immunotherapy Agent, Coxsackievirus A21, in Advanced Cancer Patients." J Immunother Cancer 2015.
Rabhadh: D'fhéadfadh nach mbeadh na deismireachtaí seo 100% cruinn i gcónaí.